These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17967570)

  • 1. Beta blockers in systolic heart failure: do physicians need more courage?
    Yilmaz MB; Refiker M
    Am Heart J; 2007 Nov; 154(5):e23; author reply e25. PubMed ID: 17967570
    [No Abstract]   [Full Text] [Related]  

  • 2. Surrogate end points in heart failure trials.
    Gheorghiade M; Adams KF; Gattis WA; Teerlink JR; Orlandi C; O'Connor CM
    Am Heart J; 2003 Feb; 145(2 Suppl):S67-70. PubMed ID: 12594457
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-blockers in elderly patients with heart failure ready for prime time?
    Lainscak M; Duengen HD; Anker SD
    J Am Coll Cardiol; 2009 Dec; 54(23):2202. PubMed ID: 19942096
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should chronic heart failure patients with reduced left-ventricular ejection fraction receive angiotensin-receptor blockers?
    Pitt B
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):70-1. PubMed ID: 16265371
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
    MMW Fortschr Med; 2003 Jun; 145(25):56. PubMed ID: 12891860
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-blockers in cardiac insufficiency. Time to reconsider?].
    Follath F
    Schweiz Med Wochenschr; 1996 May; 126(18):747-9. PubMed ID: 8693298
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blockers for systolic dysfunction.
    Lovinger SP
    J Fam Pract; 2001 Nov; 50(11):996. PubMed ID: 11711024
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.
    Kjekshus J
    Eur J Heart Fail; 2007 Sep; 9(9):962; author reply 962-3. PubMed ID: 17652021
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept.
    Meyer M; Rambod M; LeWinter M
    Heart Fail Rev; 2018 Jul; 23(4):499-506. PubMed ID: 29098508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Question: does beta-blocker therapy improve outcomes in patients with congestive heart failure with normal left ventricular function (diastolic dysfunction)?
    Cafaro B; Barr S; Brand JL
    J Okla State Med Assoc; 2010 Feb; 103(2):51-2. PubMed ID: 20306621
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome.
    Leszek P; Kruszewski M
    Am Heart J; 2008 Mar; 155(3):e25; author reply e19. PubMed ID: 18294469
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequate treatment of congestive heart failure in dialysis patients.
    Bouchard J; Madore F
    Semin Dial; 2007; 20(5):383-6. PubMed ID: 17897240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
    Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.